article thumbnail

Sana Biotechnology inks $50M deal for precise gene editing system from Beam Therapeutics

GeekWire

Sana Biotechnology has a new $50 million tool in its toolbox. That’s according to a study in Nature Communications led by CRISPR pioneer Feng Zhang at the Broad Institute of MIT and Harvard, which has licensed its technology to Beam. The application with the U.S. Sana CEO and president Steve Harr. Sana Photo).

article thumbnail

Cell therapy startup Immusoft lands deal with Takeda worth potentially more than $900M

GeekWire

Under the agreement, Takeda has options to exclusively license programs at the preclinical stage and will take products to the clinic and through commercialization. The company aims to file an investigational new drug application for the condition with the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Seattle-based Icosavax, which is developing COVID-19 vaccines, files for IPO 4 years after launch

GeekWire

Icosavax creates virus-like particles with technology licensed from the University of Washington’s Institute for Protein Design. Icosavax filed a clinical trial application in Belgium in June for its RSV candidate and plans to initiate trials later this year, according to a company filing with the U.S. Icosavax Photo).

article thumbnail

2021 Predictions: Why these tech, science and startup leaders are upbeat about the year ahead

GeekWire

And I’ll earn my A-class license on iRacing…. The hottest technology of 2021: We can expect that AI (and generally everything ML-driven) will remain a super hot technology in 2021, especially with applications in medicine and other areas. The hottest technology of 2021: Investments and advances in augmented reality applications.

Industry 145